title: Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis.
authors.affiliation: Division of Pulmonary Biology, Children's Hospital Research Foundation, Cincinnati, Ohio 45229-3039, USA. korft0@chmcc.org
authors.forename: T R
authors.initials: TR
authors.lastname: Korfhagen
mesh_terms: D001419:Bacteria / Q000378:metabolism*; D001422:Bacterial Adhesion / Q000187:drug effects / Q000502:physiology; D001424:Bacterial Infections / Q000150:complications / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D002630:Chemotactic Factors / Q000494:pharmacology; D002633:Chemotaxis / Q000187:drug effects / Q000502:physiology; D003550:Cystic Fibrosis / Q000150:complications / Q000276:immunology / Q000378:metabolism*; D004198:Disease Susceptibility; D005609:Free Radicals; D006023:Glycoproteins / Q000494:pharmacology / Q000502:physiology; D008024:Ligands; D008168:Lung / Q000382:microbiology*; D008262:Macrophage Activation / Q000187:drug effects; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000502:physiology*; D009000:Monocytes / Q000276:immunology / Q000378:metabolism; D009928:Organ Specificity; D010587:Phagocytosis / Q000187:drug effects / Q000502:physiology*; D018410:Pneumonia, Bacterial / Q000209:etiology / Q000276:immunology / Q000378:metabolism; D011510:Proteolipids / Q000494:pharmacology / Q000502:physiology*; D011550:Pseudomonas aeruginosa / Q000378:metabolism; D037662:Pulmonary Surfactant-Associated Protein A; D037663:Pulmonary Surfactant-Associated Protein D; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000494:pharmacology / Q000502:physiology*
chemical_list: D002630:Chemotactic Factors; D005609:Free Radicals; D006023:Glycoproteins; D008024:Ligands; D011510:Proteolipids; D037662:Pulmonary Surfactant-Associated Protein A; D037663:Pulmonary Surfactant-Associated Protein D; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants